Medical Nitrous Oxide Market Size is valued at USD 1.76 Bn in 2023 and is predicted to reach USD 3.03 Bn by the year 2031 at a 7.22% CAGR during the forecast period for 2024-2031.
Medical nitrous oxide, often known as N2O, is a colourless and odourless gas that has been utilized in medical settings for over a century. It is popularly referred to as "laughing gas" because of the euphoric effects it produces when inhaled in small doses. Nitrous oxide is used in medicine to relieve pain and provide anaesthesia during procedures. Nitrous oxide has weak anaesthetic effects, offering pain relief and mild drowsiness when inhaled in controlled quantities. It is frequently used as an adjunctive medication alongside other anaesthetics to give balanced anaesthesia during surgical procedures.
Nitrous oxide is regarded for its analgesic properties, which reduce pain and suffering during medical treatments. It affects the central nervous system, modulating pain perception and decreasing the severity of painful stimuli. One of the primary advantages of nitrous oxide is its quick onset and offset of action. It takes effect within minutes of inhalation and is quickly removed from the body after withdrawal, giving you exact control over the depth and duration of anaesthesia. Pain management and patient comfort are becoming increasingly important in healthcare settings. Medical nitrous oxide is valued for its rapid onset and duration of action, making it a popular choice for pain management during various medical operations.
Advances in nitrous oxide delivery systems and equipment improve the safety, precision, and efficiency of nitrous oxide administration. Modern equipment enables the exact control of nitrous oxide concentrations, which leads to better patient outcomes and satisfaction. Nitrous oxide is increasingly employed in various medical professions, including dentistry, obstetrics, emergency medicine, and outpatient surgery. Its adaptability and efficiency make it a useful tool in various healthcare settings. Healthcare professionals and patients are becoming more familiar of the benefits & risks associated with medical nitrous oxide. As more evidence supports its usefulness and safety, nitrous oxide is becoming a popular pain treatment and anaesthetic choice.
Competitive Landscape
Some Major Key Players In The Medical Nitrous Oxide Market:
- Air Liquide (Airgas)
- Air Products
- American Welding & Gas.
- Calox
- Carbide And Chemicals
- Chengdu Taiyu Industrial Gases Co., Ltd.
- Earlbeck Gases & Technologies
- Ellenbarrie Industrial Gases.
- Gulf Cryo
- Jiangsu Huazhong Gas Co., Ltd.
- Linde Plc
- Matheson Tri-Gas,Inc
- Messer Se & Co. Kgaa
- Nexair
- Norco Inc.
- Oxygen & Argon Works Ltd
- Sol Spa
- Southern Gas Limited
- Steelman Gases Pvt. Ltd.
- Taiyo Nippon Sanso Corporation
- Other prominent players
Market Segmentation:
The Medical Nitrous Oxide Market is segmented by product, Application and end user. According to the Product segment, the market is segmented into gaseous and liquid stateste. By Application, the market is segmented into anaesthesia and pain relief, cryosurgery, and surgical insufflation. The end user segment comprises hospitals, home healthcare, and academic & research institutions.
Based On Application, The Anaesthesia And Pain Relief Section Emerged As The Dominant Category.
The anaesthetic and pain relief section emerged as the dominant category, accounting for the highest market share. The dominance of anaesthesia and pain relief applications in the medical nitrous oxide market is attributed to their critical roles in surgical and medical procedures. Nitrous oxide, known for its anaesthetic and analgesic qualities, is widely used in healthcare settings due to its ability to induce conscious sedation and relieve pain during various medical treatments. This dominance is obvious in the widespread use of nitrous oxide by healthcare professionals, who take advantage of its ability to offer quick and regulated sedation, considerably improving patient comfort and procedure outcomes.
The Home Healthcare Segment Is Expected To Register The Highest Growth.
The home healthcare segment is predicted to increase the most. This is primarily due to changing healthcare trends and a rising preference for healthcare services provided in the comfort of patients' homes. Medical nitrous gas is becoming increasingly used in home healthcare settings as a pain treatment and some medical procedures outside of regular healthcare institutions. The convenience, flexibility, and personalized nature of home healthcare contribute to the significant growth of the medical nitrous oxide market in this category.
In The Region, The North American Medical Nitrous Oxide Market Holds A Significant Revenue Share.
North America was the main regional market for nitrous oxide in 2022, accounting for the majority of sales. The growing demand for nitrous oxide from various industries, including automotive, food and beverage, and healthcare, is driving market expansion. As the prevalence of chronic diseases in the region has risen, so has the demand for medical-grade nitrous oxide, which is used for anaesthesia and pain relief. Furthermore, the Asia Pacific market is estimated to have the highest revenue CAGR throughout the projected period, owing to the region's rapid expansion and urbanization. The growth of the food & beverage industries in nations such as China and India is increasing regional demand for nitrous oxide. The rising usage of nitrous oxide in the automobile industry to improve engine performance and reduce emissions is driving the regional market forward.
Recent Developments:
- In Aug 2022, Linde Thailand increased its production of Ultra High Purity Nitrous Oxide (UHP N2O) to enhance its service to customers in South-East Asia. They prioritized upholding high-quality standards and mitigating supply chain risks, drawing on their 50 years of experience in the Thailand market.
- In Oct 2020, nexAir purchased Atlanta Medical Gases' business operations and clientele. Atlanta Medical Gases' healthcare customers enhanced nexAir's medical gas position in the greater Atlanta area as part of the acquisition. The acquisition allowed Atlanta Medical Gases customers to take advantage of nexAir's product range.
Medical Nitrous Oxide Market Report Scope
Report Attribute |
Specifications |
Market Size Value In 2023 |
USD 1.76 Bn |
Revenue Forecast In 2031 |
USD 3.03 Bn |
Growth Rate CAGR |
CAGR of 7.22% from 2024 to 2031 |
Quantitative Units |
Representation of revenue in US$ Bn, Volume (KT) and CAGR from 2024 to 2031 |
Historic Year |
2019 to 2023 |
Forecast Year |
2024-2031 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
By Product, Application, End-User |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
Competitive Landscape |
Southern Gas Limited (India), Jiangsu Huazhong Gas Co., Ltd. (China), American Welding & Gas (US), Carbide and Chemicals (India), nexAir (US), Air Liquide (Paris), Linde plc (Ireland), Messer SE & CO. KGAA (Germany), SOL SpA (Italy), Chengdu Taiyu Industrial Gases Co., Ltd. (China), Oxygen & Argon Works Ltd (Israel), Matheson Tri-Gas Inc. (US), CalOx (US), Steelman Gases Pvt. Ltd. (India), Earlbeck Gases & Technology (US), Ellenbarrie Industrial Gases (India), Norco Inc. (US), Gulf Cryo (UAE), and other prominent players |
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |